Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis

Mediators of Inflammation

Volumn 7, Issue 3, 1998, Pages 169-173

  Van Bergeijk, J D ^a,c   Van Meeteren, M E ^b   Tak, C J A M ^b   Van Dijk, A P M ^b   Meijssen, M A C ^a   Wilson, J H P ^a   Zijlstra, F J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

Dextran sulphate; Experimental colitis; Intestinal inflammation; Neuropeptide; Somatostatin

Indexed keywords

DEXTRAN; NEUROPEPTIDE; OCTREOTIDE; SOMATOSTATIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; COLITIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; INFLAMMATORY CELL; INTESTINE INJURY; MACROPHAGE FUNCTION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBMUCOSA;

ANIMALS; COLITIS; DEXTRAN SULFATE; FEMALE; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; SOMATOSTATIN;

ANIMALIA;

EID: 0031846256     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359891108     Document Type: Conference Paper

References (33)

1. Stanisz AM. Neuroimmunomodulation in the gastrointestinal tract. Ann NY Acad Sci 1994; 741: 64-72.
2. van Hagen PM, Krenning EP, Kwekkeboom DJ. et al. Somatostatin and the immune and haematopoetic system; a review. Eur J Clin Invest 1994; 24: 91-99.
3. Blum AR, Mctwali A, Mathew RC, Cook G, Eliott D, Weinstock JV. Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFNgamma secretion. J Immunol 1992; 149: 3621-3626.
4. Elliott DE, Weinstock JV. Granulomas in murine Schistosomiasis mansoni have a somatostatin immunoregulatory circuit. Metabolism 1996; 45 (suppl 1): 88-90.
5. Watanabe T. Kubota Y, Sawada T. Muto T. Distribution and quantification of somatostatin in inflammatory disease. Dis Colon Rectum 1992; 35: 488-194.
6. Koch TR, Carney JA, Morris VA, Go VLW. Somatostatin in the idiopathic inflmmatory bowel disease. Dis Colon Rectum 1988; 31: 198-203.
7. Yamamoto H, Morise K, Kusugami K, et al. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease. J Gastroenterol 1996; 31: 525-532.
8. Eliakim R, Karmeli F, Rechmilewitz D. Decreased somatostatin (SS) generation by colonic mucosa in active ulcerative colitis. Gastroenterology 1991; 100: A578.
9. Payer J, Huorka M, Duris I, et al. Plasma somatostatin levels in ulcerative colitis. Hepato-Gastroenterol 1994; 41: 552-553.
10. Binimelis J, Webb SM, Mones J. et al. Circulation immunoreactive somatostatin in gastrointestinal diseases. Decrease after vagotomy and enhancement in active ulcerative colitis. irritable bowel syndrome, and duodenal ulcer. Scand J Gastroenterol 1987; 22: 931-937.
11. Eliakim R, Karmeli F, Okon E, Rachmilewitz D. Octreotide effectively decreases mucosal damage in experimental colitis. Gut 1993; 34: 264-269.
12. Dziarski R. Synergistic enhancement ofT cell responses and interlcukin-1 receptor expression by interlcukin-1 and heparin or dextran sulfate. Cell Immunol 1992; 145: 100-110.
13. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP. Elson CO. Dextran sulfate sodium (DSS)-induced colitis occurs in severe combined immunodeficient (SCID) mice. Gastroenterology 1994; 107: 1613-1652.
14. Axelsson L-G, Landstrom B, Gronberg A, Bylund-Fellenius A-C. Dextran sulphate sodium (DSS) induces experimental colitis in CD4+-cell depleted, athymic and NK cell depleted SCID mice. Gut 1996; 38: A638.
15. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of indflammatory bowel disease. Gastroenterology 1995; 109: 1344-1367.
16. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 1990; 98: 694-702.
17. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-249.
18. Zijlstra FJ, van Dijk JPM, Wilson JHP. Increased platelet activating factor synthesis in experimental colitis after diclofenac and 5-amino-salicylic acid. Eur J Pharmacol 1993; 249: R1-R2.
19. Domek MJ, Iwata F, Blackman EI, et al. Anti-neutrophil serum attenuates dextran sulfate sodium-induced colonic damage in the rat. Scand J Gastroenterol 1995; 30: 1089-1094.
20. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993; 38: 1722-1734.
21. Björek S, Jennische E, Dahlstrom A, Ahlman H. Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats Dig Dis Sci 1997; 42: 821-832.
22. Partsch G, Matucci-Cerinic M, Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro. Inflammation 1992; 16: 539-547.
23. Wiedermann CJ, Reinisch N, Braunsteiner H. Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood 1993; 82: 954-960.
24. Miller SK, Martindale RG, Gao XX, Gadacz TR. The effects of octreotide on healing of small bowel anastomosis. Am Surg 1996; 62: 733-737.
25. Mulvihill SJ, Pappas TN, Fonkalsrud EW, Debas HT. The effect of somatostatin on experimental intestinal obstruction. Ann Surg 1988; 207: 169-173.
26. Benes G. Octreotide acetete (Sandostatin) to control the symptoms of Crohn's disease. Am J Gastroenterol 1993; 88: 1603.
27. Dorta G, Schnegg JF, Saraga E, Schmied PA. Treatment of gold-induced enteritis with octreotide. Lancet 1993; 342: 179.
28. Van Dijk APM, Keuskamp ZJ, Wilson JHP, Zijlstra FJ. Sequential release of cytokines, lipid mediators and nitrogen oxide in experimental colitis. Mediators Inflamm 1995; 4: 186-190.
29. Minocha A, Thomas C, Omar R, Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice. Dig Dis Sci 1995; 40: 1757-1762.
30. Ni J, Chen SF. Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 1996; 39: 234-241.
31. Dieleman LA. Chapter 3.2. Chronic experimental colitis by dextran sulfate sodium (DSS) is Th1-mediated. In: Human and Experimental Studies of Acute and Chronic Intestinal Inflammation. Relevance to the Pathogenesis and Treatment of Inflammatory Bowel Disease. Amsterdam: Free University, 1995.
32. Dieleman LA, Bloemena E, van der Ende MB, Peña AS, van Rees EP. No beneficial effect of interleukin-10 in dextran sulfate sodium-induced colitis. Gastroenterology 1997; 112, Ag60.
33. Thompson JS, Nguyen B-LT, Harty RF. Somatostatin analogue inhibits intestinal regeneration Arch Surg 1993; 128: 385-389.